INKP-100 sodium phosphate tablet: INKP began enrolling 90 patients in a Phase II dose-ranging trial

InKine Pharmaceutical Co. Inc. (INKP), Blue

Read the full 63 word article

How to gain access

Continue reading with a
two-week free trial.